clodronic acid has been researched along with Low Bone Density in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (63.64) | 18.2507 |
| 2000's | 6 (27.27) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mészaros, Á; Veszelyné Kotán, E | 1 |
| Brufsky, AM | 1 |
| Ala-Kaila, K; Aranko, SM; Blåfield, H; Koivunoro, K; Kormano, M; Laitinen, K; Mäkinen, L; Patronen, A; Perttilä, J; Puolijoki, H; Pylkkänen, L; Rekiaro, M; Sairanen, S; Salmi, J; Seppänen, J; Väisänen, K; Välimäki, MJ; Vesterinen, K | 1 |
| Aiello, M; Campana, C; D'Armini, A; Goggi, C; Ippoliti, G; Pellegrini, C; Rinaldi, M; Viganò, M | 1 |
| Hershman, D; Narayanan, R | 1 |
| Katajamäki, A; Laitinen, K; Risteli, J; Seppänen, J; Tähtelä, R; Välimäki, MJ | 1 |
| Alhava, E; Arnala, I; Lappalainen, R; Nevalainen, T; Olkkonen, H; Tarvainen, R | 1 |
| Holmström, T; Nyman, MT; Paavolainen, P; Penttinen, R; Verkasalo, M | 1 |
| Kanis, JA | 1 |
| Arnala, I; Lauren, L; Nyman, MT; Paavolainen, P | 1 |
| Hannuniemi, R; Jalovaara, P; Kippo, K; Laurén, L; Lepola, VT; Osterman, T; Sellman, R; Väänänen, HK; Virtamo, T | 1 |
| Hannuniemi, R; Kippo, K; Laurén, L; Osterman, T; Pasanen, I; Sellman, R; Väänänen, K; Virtamo, T | 1 |
| Hannuniemi, R; Isaksson, P; Kippo, K; Laurén, L; Osterman, T; Pasanen, I; Peng, Z; Sellman, R; Väänänen, HK; Virtamo, T | 1 |
| Hannuniemi, R; Isaksson, P; Kippo, K; Kuurtamo, P; Laurén, L; Osterman, T; Peng, Z; Sellman, R; Tuukkanen, J; Väänänen, HK | 1 |
| Grotz, W; Niessen, A; Rump, JA; Schmidt-Gayk, H; Schollmeyer, P | 1 |
| Hannuniemi, R; Isaksson, P; Kippo, K; Kuurtamo, P; Laurén, L; Osterman, T; Peng, Z; Sellman, R; Väänänen, HK; Virtamo, T | 1 |
| Grotz, WH; Kirste, G; Niessen, A; Olschewski, M; Reichelt, A; Rump, LC; Schmidt-Gayk, H; Schollmeyer, PJ | 1 |
| Cocchi, D; Paganelli, C; Zaffe, D | 1 |
| Laitinen, K; Taube, T | 1 |
| Imai, Y; Itoh, F; Kojima, M; Komatsu, H; Komatsu, Y; Shiraki, M; Taya, F | 1 |
| Hernández, ER; Revilla, M; Rico, H; Sánchez-Atrio, A; Seco, C; Valencia, MJ; Villa, LF | 1 |
| Abbaszadegan, H; Adolphson, P; Bodén, H; Henriques, T; Salemyr, M | 1 |
4 review(s) available for clodronic acid and Low Bone Density
| Article | Year |
|---|---|
[Therapeutic practice of bisphosphonate use and related pharmaceutical issues I].
Topics: Alendronate; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Neoplasms; Clodronic Acid; Diphosphonates; Fractures, Bone; Humans; Hungary; Ibandronic Acid; Imidazoles; Osteoporosis; Pamidronate; Risedronic Acid; Zoledronic Acid | 2016 |
The evolving role of bone-conserving therapy in patients with breast cancer.
Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Female; Humans; Imidazoles; Survival Analysis; Zoledronic Acid | 2010 |
Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer.
Topics: Absorptiometry, Photon; Alendronate; Antineoplastic Agents; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Breast Neoplasms; Calcitonin; Calcium; Clodronic Acid; Diphosphonates; Drug Therapy, Combination; Estrogens; Etidronic Acid; Female; Humans; Imidazoles; Male; Osteoporosis; Prostatic Neoplasms; Quality of Life; Risedronic Acid; Risk Factors; Treatment Outcome; Vitamin D; Zoledronic Acid | 2004 |
Bone and cancer: pathophysiology and treatment of metastases.
Topics: Analgesics, Non-Narcotic; Bone and Bones; Bone Diseases, Metabolic; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Hypercalcemia; Pain; Pamidronate; Parathyroid Hormone | 1995 |
7 trial(s) available for clodronic acid and Low Bone Density
| Article | Year |
|---|---|
Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study.
Topics: Absorptiometry, Photon; Bone Density; Bone Diseases, Metabolic; Clodronic Acid; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hip Joint; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Spinal Diseases | 2002 |
Clodronate treatment of established bone loss in cardiac recipients: a randomized study.
Topics: Adult; Aged; Antimetabolites; Bone Density; Bone Diseases, Metabolic; Clodronic Acid; Disease-Free Survival; Female; Fractures, Bone; Graft Survival; Heart Transplantation; Humans; Incidence; Male; Middle Aged; Postoperative Complications | 2003 |
Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
Topics: Acid Phosphatase; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Clodronic Acid; Collagen; Collagen Type I; Double-Blind Method; Drug Monitoring; Female; Femur; Femur Neck; Follow-Up Studies; Humans; Isoenzymes; Lumbar Vertebrae; Middle Aged; Peptide Fragments; Peptides; Postmenopause; Procollagen; Tartrate-Resistant Acid Phosphatase; Treatment Outcome | 2005 |
Treatment of bone pain after kidney transplantation.
Topics: Absorptiometry, Photon; Biomarkers; Bone Density; Bone Diseases, Metabolic; Calcitonin; Calcium; Clodronic Acid; Female; Humans; Kidney Transplantation; Male; Middle Aged; Osteoporosis; Pain; Pain Measurement; Postoperative Complications | 1998 |
Treatment of osteopenia and osteoporosis after kidney transplantation.
Topics: Administration, Intranasal; Administration, Oral; Adult; Bone Density; Bone Diseases, Metabolic; Calcitonin; Calcium; Clodronic Acid; Female; Humans; Kidney Transplantation; Male; Middle Aged; Osteoporosis; Pilot Projects; Postoperative Complications; Prospective Studies; Sex Characteristics | 1998 |
Clodronate as a cause of aminotransferase elevation.
Topics: Alanine Transaminase; Analgesics, Non-Narcotic; Analysis of Variance; Aspartate Aminotransferases; Bone Diseases, Metabolic; Clodronic Acid; Double-Blind Method; Female; Humans; Prospective Studies | 1999 |
Clodronate increases mineralization of callus after Colles' fracture: a randomized, double-blind, placebo-controlled, prospective trial in 32 patients.
Topics: Absorptiometry, Photon; Aged; Bone Density; Bone Diseases, Metabolic; Bony Callus; Clodronic Acid; Colles' Fracture; Diphosphonates; Disease Progression; Double-Blind Method; Female; Fracture Healing; Humans; Middle Aged; Postmenopause; Prospective Studies; Radionuclide Imaging; Range of Motion, Articular; Splints; Treatment Outcome | 2000 |
11 other study(ies) available for clodronic acid and Low Bone Density
| Article | Year |
|---|---|
Clodronate prevents immobilization osteopenia in rats.
Topics: Animals; Bone Density; Bone Diseases, Metabolic; Calcium; Clodronic Acid; Dose-Response Relationship, Drug; Female; Immobilization; Magnesium; Phosphorus; Rats; Rats, Wistar; Sciatic Nerve; Tibia | 1994 |
Clodronate reduces plate osteopenia in the rabbit.
Topics: Animals; Bone Diseases, Metabolic; Bone Plates; Bone Resorption; Calcium; Clodronic Acid; Male; Rabbits; Tibia | 1993 |
Short term clodronate treatment does not increase trabecular bone in posttraumatic osteopenia.
Topics: Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Calcium; Clodronic Acid; Femur; Kinetics; Male; Rabbits | 1995 |
Bisphosphonates clodronate and etidronate in the prevention of ovariectomy-induced osteopenia in growing rats.
Topics: Analysis of Variance; Animals; Bone Diseases, Metabolic; Clodronic Acid; Disease Models, Animal; Dose-Response Relationship, Drug; Etidronic Acid; Female; Femur Neck; Injections, Subcutaneous; Lumbar Vertebrae; Ovariectomy; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tibia | 1996 |
Slow-release clodronate in prevention of inflammation and bone loss associated with adjuvant arthritis.
Topics: Alkaline Phosphatase; Analysis of Variance; Animals; Arthritis, Experimental; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Calcium; Clodronic Acid; Delayed-Action Preparations; Drug Administration Schedule; Inflammation; Injections, Intravenous; Male; Osteocalcin; Rats; Rats, Inbred Lew | 1997 |
Clodronate prevents bone loss in aged ovariectomized rats.
Topics: Aging; Amino Acids; Animals; Body Weight; Bone and Bones; Bone Diseases, Metabolic; Clodronic Acid; Eating; Estradiol; Female; Osteocalcin; Ovariectomy; Rats; Rats, Sprague-Dawley | 1997 |
Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
Topics: Administration, Oral; Alkaline Phosphatase; Amino Acids; Animals; Biomarkers; Biomechanical Phenomena; Bone Density; Bone Diseases, Metabolic; Clodronic Acid; Diaphyses; Estrogens; Female; Hindlimb; Humans; Lumbar Vertebrae; Osteocalcin; Ovariectomy; Rats; Rats, Sprague-Dawley | 1998 |
Effect of clodronate treatment on established bone loss in ovariectomized rats.
Topics: Amino Acids; Animals; Biomechanical Phenomena; Bone Diseases, Metabolic; Bone Remodeling; Clodronic Acid; Female; Femur; Lumbar Vertebrae; Osteocalcin; Ovariectomy; Rats; Rats, Sprague-Dawley; Tibia; Weight-Bearing | 1998 |
Induction and pharmacological treatment of oral osteopenia in rats.
Topics: Animals; Bone Diseases, Metabolic; Clodronic Acid; Disease Models, Animal; Estradiol; Female; Fractures, Bone; Male; Mandibular Fractures; Maxillary Fractures; Osteoporosis; Placebos; Rats; Rats, Sprague-Dawley | 1999 |
Treatment effects of bisphosphonates on ovariectomy-induced osteopenia in rats: comparison between clodronate and etidronate.
Topics: Amino Acids; Animals; Bone Density; Bone Diseases, Metabolic; Calcium; Clodronic Acid; Etidronic Acid; Female; Lumbar Vertebrae; Ovariectomy; Rats; Rats, Sprague-Dawley | 1999 |
Calcitonin versus clodronate in the prevention of ovariectomy-induced osteopenia in rats.
Topics: Absorptiometry, Photon; Animals; Bone Density; Bone Diseases, Metabolic; Calcitonin; Clodronic Acid; Disease Models, Animal; Female; Femur; Injections, Subcutaneous; Ovariectomy; Rats; Rats, Wistar; Spine; Treatment Outcome | 2000 |